Radiomedix, Inc.
Quick facts
Phase 3 pipeline
- 64Cu-DOTATATE · Oncology; Diagnostic Imaging
64Cu-DOTATATE is a radioactive diagnostic imaging agent that binds to somatostatin receptors on neuroendocrine tumor cells, allowing detection via positron emission tomography (PET).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: